Study to Evaluate Persistence of Antibodies After Vaccination With Meningococcal Vaccine GSK 134612

Clinical trial NCT00974363 · COMPLETED

Trial details

NCT number: NCT00974363
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Infections, Meningococcal

Start date: 2009-09-01
Primary completion: 2013-05-01
Enrollment: 697

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.